Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis
Jochen Buechner(Oslo University Hospital), Susana Rives(Hospital Sant Joan de Déu Barcelona), Kara L. Davis(Stanford Medicine), Hidefumi Hiramatsu(Kyoto University), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Gary Douglas Myers(Baylor College of Medicine), Krysta Schlis(Oregon Health & Science University), Peter Bader(Goethe University Frankfurt), Eneida R. Nemecek(Oregon Health & Science University), Muna Qayed(Emory University), Shannon L. Maude(Children's Hospital of Philadelphia), Heather E. Stefanski(National Marrow Donor Program), Karen Thudium Mueller(Unknown), Barbara De Moerloose(Ghent University Hospital), Michael Boyer(Chris O’Brien Lifehouse), Stephan A. Grupp(Children's Hospital of Philadelphia), Theodore W. Laetsch(Children's Hospital of Philadelphia), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Yiyun Zhang, Paul L. Martin(Duke University), Patricia A. Wood(Albany Stratton VA Medical Center Albany), Michael A. Pulsipher(Primary Children's Hospital), Tetiana Taran(National Cancer Center), Michael R. Verneris(NHS Blood and Transplant)
Cited by 63
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k